SEC 13F Intelligence

Antipodes Partners Ltd / NTR

Antipodes Partners Ltd’s Nutrien Ltd Position

Does Antipodes Partners Ltd own Nutrien Ltd (NTR)? Not currently — the last reported position was 460.3K shares worth $27M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$27M
Q2 2025
Shares
460.3K
% of Portfolio
+0.83%
Quarters Held
13
position exited

Position History NTR

Reported value by quarter
Q4 ’21: $42MQ4 ’21Q1 ’22: $157MQ2 ’22: $49MQ2 ’22Q3 ’22: $61MQ4 ’22: $36,131Q4 ’22Q3 ’23: $545Q4 ’23: $89,862Q4 ’23Q1 ’24: $111,101Q2 ’24: $79MQ2 ’24Q3 ’24: $44MQ4 ’24: $46MQ4 ’24Q1 ’25: $40MQ2 ’25: $27MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025460.3K$27M+0.83%
Q1 2025807.8K$40M+1.26%
Q4 20241.03M$46M+1.60%
Q3 2024925.8K$44M+1.54%
Q2 20241.54M$79M+2.86%
Q1 20242.05M$111,101+3.51%
Q4 20231.60M$89,862+2.81%
Q3 20238.7K$545+0.02%
Q4 2022494.7K$36,131+1.30%
Q3 2022726.9K$61M+2.43%
Q2 2022617.6K$49M+2.05%
Q1 20221.71M$157M+2.77%
Q4 2021600.0K$42M+1.48%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Antipodes Partners Ltd’s full portfolio or all institutional holders of NTR.